Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Suggested Citation:
"Front Matter." Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
doi: 10.17226/13146.
Glutamate is the most pervasive neurotransmitter in the central nervous system (CNS). Despite this fact, no validated biological markers, or biomarkers, currently exist for measuring glutamate pathology in CNS disorders or injuries. Glutamate dysfunction has been associated with an extensive range of nervous system diseases and disorders. Problems with how the neurotransmitter glutamate functions in the brain have been linked to a wide variety of disorders, including schizophrenia, Alzheimer's, substance abuse, and traumatic brain injury. These conditions are widespread, affecting a large portion of the United States population, and remain difficult to treat.
Efforts to understand, treat, and prevent glutamate-related disorders can be aided by the identification of valid biomarkers. The Institute of Medicine's Forum on Neuroscience and Nervous System Disorders held a workshop on June 21-22, 2010, to explore ways to accelerate the development, validation, and implementation of such biomarkers. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary investigates promising current and emerging technologies, and outlines strategies to procure resources and tools to advance drug development for associated nervous system disorders. Moreover, this report highlights presentations by expert panelists, and the open panel discussions that occurred during the workshop.
Institute of Medicine. 2011. Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary. Washington, DC: The National Academies Press.
Sign in to access your saved publications, downloads, and email
preferences.
Former MyNAP users: You'll need to reset your password on your first
login to MyAcademies. Click "Forgot password" below to receive a reset
link via email. Having trouble?
Visit our FAQ page
to contact support.
Members of the National Academy of Sciences, National Academy of
Engineering, or National Academy of Medicine should log in through their
respective Academy portals.
Register
Register
Thank You
Thank You
Thank you for creating a MyAcademies account!
Enjoy free access to thousands of National Academies' publications, a
10% discount off every purchase, and build your personal library.
Forgot Password
Forgot Password
Enter the email address for your MyAcademies (formerly MyNAP) account to
receive password reset instructions.
Reset Requested
Reset Requested
We sent password reset instructions to
your email
. Follow the link in that email to create a new password. Didn't receive
it? Check your spam folder or
contact us
for assistance.
We sent a verification link to your email. Please check your inbox (and
spam folder) and follow the link to verify your email address. If you
did not receive the email, you can request a new verification link below